Collaboration pairs leadership in pharmaceuticals and advanced drug delivery technology to support a consistent, reliable treatment experience for metabolic disease patients. FRANKLIN LAKES, N.J....
The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has declared a quarterly dividend of $1.05 per common...
I’m proud to share the recent launch of BD’s 2025 Sustainability Report, a reflection of the meaningful progress we have made in delivering on our purpose of advancing the world of health. ....
First-ever disease focused fellowship program supports specialized endovascular training for physicians across Europe By Jane Hart, VP of Clinical Affairs, BD Interventional – Peripheral...
In just one day, BD associates help non-profits solve real operational challenges, delivering everything from strategy and communications plans to AI-driven tools, frameworks and measurable outcomes.
Discover the new BD. We create medical technology, devices and laboratory equipment for scores of different needs across the healthcare continuum. But we serve all of them with one single and relentless human purpose: advancing the world of health. This is how we make a difference in human health across generations. This is our work and this is our passion.
The BD Innovation and Engagement Center in Eysins Switzerland offers visiting healthcare professionals a collaborative and immersive environment to grasp the full scope of BD solutions to healthcare challenges across the care continuum.
